When Alzheimer's disease prevention becomes policy: regulatory speed, commercialisation, and risk

The Lancet Neurology 2026

View at publisher

Authors: Lon Schneider

DOI: 10.1016/s1474-4422(26)00055-4

Cited by: 2

References: 4

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Health Systems Economic Evaluations Quality of Life Global Public Health Policies and Epidemiology

References 4